
浏览全部资源
扫码关注微信
1.200433 上海,海军军医大学(第二军医大学)附属长海医院消化内科
2.32224美国佛罗里达州,美国Mayo Clinic肿瘤生物系
[李兆申,E-mail: zhsli@81890.net LI Zhaoshen, E-mail: zhsli@81890.net
收稿:2018-01-29,
修回:2018-03-17,
纸质出版:2018-07-30
移动端阅览
姚瑶, 庄璐, 林堃, 等. 卡莫司他对小鼠急性胰腺炎治疗作用的初步探究[J]. 第三军医大学学报, 2018,40(14):1291-1294.
Yao YAO, Lu ZHUANG, Kun LIN, et al. Therapeutic effect of camostat in a mouse model of acute pancreatitis[J]. Journal of Third Military Medical University, 2018, 40(14): 1291-1294.
姚瑶, 庄璐, 林堃, 等. 卡莫司他对小鼠急性胰腺炎治疗作用的初步探究[J]. 第三军医大学学报, 2018,40(14):1291-1294. DOI: 10.16016/j.1000-5404.201801230.
Yao YAO, Lu ZHUANG, Kun LIN, et al. Therapeutic effect of camostat in a mouse model of acute pancreatitis[J]. Journal of Third Military Medical University, 2018, 40(14): 1291-1294. DOI: 10.16016/j.1000-5404.201801230.
目的
2
探究胰蛋白酶制剂卡莫司他对雨蛙素诱导的急性胰腺炎的作用。
方法
2
用雨蛙素腹腔注射法诱导C57BL/6J小鼠建立急性胰腺炎模型,以卡莫司他灌胃法为治疗组,生理盐水灌胃法为对照组。通过观察小鼠行为学的变化和检测各组小鼠血清淀粉酶水平,比较胰腺质量/体质量、胰腺组织病理变化等指标,分析炎症的不同损伤程度及变化。
结果
2
治疗组小鼠的胰腺质量/体质量和血清淀粉酶水平均低于非治疗组;非治疗组C57BL/6J小鼠注射雨蛙素后有急性胰腺炎的典型病理组织学改变,而治疗组小鼠则炎症明显改善,水肿及坏死均减轻,炎症细胞浸润减少。治疗组和对照组之间的胰腺质量/体质量和血清淀粉酶水平比较差异均没有统计学意义。
结论
2
卡莫司他可通过抑制胰腺蛋白酶活性减轻急性胰腺炎的炎症严重程度。
Objective
2
To explore the therapeutic effect of camostat
a trypsinogen inhibitor
on cerulein-induced acute pancreatitis in mice.
Methods
2
A mouse model of acute pancreatitis was established by intraperitoneal injection of cerulein and treated with camostat (camostat treatment group) or normal saline (model group) administered by oral gavage
with mice receiving both intraperitoneal injection and oral gavage of saline serving as the control group. The changes in the behaviors
serum amylase levels
pancreas/body weight ratio and pancreas histology of the mice were observed after the treatment to evaluate the changes in the inflammation.
Results
2
Compared with the mice in the model group
the mice in camostat treatment group showed significantly lowered pancreas/body weight ratio and serum amylase level with obviously alleviated pancreatic edema
necrosis and inflammatory cell infiltration. No significant difference was found in pancreas/body ratio or serum amylase between camostat treatment group and the control group.
Conclusion
2
In the mouse model of cerulein-induced acute pancreatitis
camostat treatment alleviates the inflammation by inhibiting trypsin activity
which highlights the role of trypsin in the process of acute pancreatitis.
PANDOL S J, SALUJA A K, IMRIE C W, et al. Acute pancreatitis: bench to the bedside[J]. Gastroenterology, 2007, 132(3): 1127-1151. DOI: 10.1053/j.gastro.2007.01.055.
SAH R P, DAWRA R K, SALUJA A K. New insights into the pathogenesis of pancreatitis[J]. Curr Opin Gastroenterol, 2013, 29(5): 523-530. DOI: 10.1097/MOG.0b013e3283 63e399.
TONSI A F, BACCHION M, CRIPPA S, et al. Acute pancreatitis at the beginning of the 21st century: the state of the art[J]. World J Gastroenterol, 2009, 15(24): 2945-2959. DOI: 10.3748/wjg.15.2945.
XUE J, SHARMA V, HABTEZION A. Immune cells and immune-based therapy in pancreatitis[J]. Immunol Res, 2014, 58(2-3): 378-386. DOI: 10.1007/s12026-014-8504-5.
SKIPWORTH J R, NIJMEIJER R M, VAN SANTVOORT H C, et al. The effect of renin angiotensin system genetic variants in acute pancreatitis[J]. Ann Surg, 2015, 261(1): 180-188. DOI: 10.1097/SLA.0000000000000655.
JI B, GAISER S, CHEN X, et al. Intracellular trypsin induces pancreatic acinar cell death but not NF-kappaB activation[J]. J Biol Chem, 2009, 284(26): 17488-17498. DOI: 10.1074/jbc.M109.005520.
JAGANNATH S, GARG P K. Novel and Experimental Therapies in Chronic Pancreatitis[J]. Dig Dis Sci, 2017, 62(7): 1751-1761. DOI: 10.1007/s10620-017-4604-0.
ISHIKURA H, NISHIMURA S, MATSUNAMI M, et al. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents[J]. Life Sci, 2007, 80(21): 1999-2004. DOI: 10.1016/j.lfs.2007.02.044.
MASSON E, LE M C, CHANDAK G R, et al. Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis.[J]. Clin Gastroenterol Hepatol, 2008, 6(1): 82-88.
GAISER S, DANILUK J, Liu Y, et al. Intracellular activation of trypsinogen in transgenic mice induces acute but not chronic pancreatitis[J]. Gut, 2011, 60(10): 1379-1388. DOI: 10.1136/gut.2010.226175.
DAWRA R, SAH R P, DUDEJA V, et al. Intra-acinar trypsinogen activation mediates early stages of pancreatic injury but not inflammation in mice with acute pancreatitis[J]. Gastroenterology, 2011, 141(6): 2210-2217. DOI: 10.1053/j.gastro.2011.08.033.
SAH R P, SALUJA A K. Trypsinogen activation in acute and chronic pancreatitis: is it a prerequisite[J]. Gut, 2011, 60(10): 1305-1307. DOI: 10.1136/gut.2011.241703.
YADAV D, LOWENFELS A B. The epidemiology of pancreatitis and pancreatic cancer[J]. Gastroenterology, 2013, 144(6): 1252-1261. DOI: 10.1053/j.gastro.2013.01.068.
EMORI Y, MIZUSHIMA T, MATSUMURA N, et al. Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats[J]. J Gastroenterol Hepatol, 2005, 20(6): 895-899. DOI:10.1111/j.1440-1746.2005.03826.x.
SANCHEZ-ALVAREZ M, M A DEL POZO, C BAKAL. AKT-mTOR signaling modulates the dynamics of IRE1 RNAse activity by regulating ER-mitochondria contacts[J]. Sci Rep, 2017. 7(1): 1-15.
LU M, LAWRENCE D A, MARSTERS S, et al. Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis[J]. Science, 2014. 345(6192): 98-101.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621